Neurodevelopmental Technique Versus Mirror Therapy in Sub-acute Stroke Patients (NCT07742020) | Clinical Trial Compass
RecruitingNot Applicable
Neurodevelopmental Technique Versus Mirror Therapy in Sub-acute Stroke Patients
Pakistan40 participantsStarted 2025-09-08
Plain-language summary
As neurodevelopmental technique and mirror therapy had different effects on lower limb coordination, functions and ambulation. Both had proven to be helpful in the stroke patients to gain functional independency. Therefore, there was need to find out the best treatment approach either NDT, mirror therapy or both are equally effective to improve motor functions, coordination and ambulation of lower limb. This study would provide the health professionals the evidence to use best technique among these according to improvement in patients' coordination, function and ambulation.The study will be randomized clinical trial. This study will be conducted at the University of Lahore. A sample size of 40 will be randomly allocated by into two experimentals groups, (20 participants in each group), by the lottery method. All the screened and willing participants will be randomly allocated to two groups (Group A: Experimental group Neurodevelopmental technique, Group B: Experimental Group mirror therapy exercise) by lottery method. This study will be a single blinded study in which assessor will be blinded.
Who can participate
Age range
45 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Age range between 45 to 65 years
* Both genders
* Sub-acute stroke hemiplegic cases; clinically stable, fully oriented and conscious.
* Both ischemic and hemorrhagic patients were be included.
* Patients with mini mental status examination (MMSE) (score \> 23)
Exclusion Criteria:
* Patients had recurrent stroke.
* Any systemic conditions that limit functions such as; cardiac diseases (exertional dyspnea, angina, Myocardial Infarction, Pacemaker) Pulmonary diseases (Asthma, Pulmonary Fibrosis etc.), Diabatic neuropathy, Diabetic foot, Varicose veins etc
* Other neurological conditions, such as; foot drop, muscular dystrophy, Myasthenia Gravis, Parkinsonism
* Any visual and hearing problem
* Any surgical and traumatic history of fractures, dislocations and/or brain injury due to any traumatic events.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is comparing two specific rehabilitation approaches — neurodevelopmental technique and mirror therapy — for people with hemiplegia after a subacute stroke; given where I am in my recovery, which of these approaches, if either, does my doctor think is more likely to suit my particular situation?
2Since this study is listed as Phase NA, meaning it may not follow the traditional drug-trial phase structure, what does that mean for how much is already known about the safety and effectiveness of these two techniques for stroke patients like me?
3The trial is focused on improving walking, lower limb movement, and coordination — can my doctor tell me how my current level of function in those areas compares to what this study seems to be looking for in participants?
4Are there standard rehabilitation therapies I should consider starting now, and if I were to discuss joining this trial, would participating in it conflict with or delay access to those standard options?
5Since the trial is actively recruiting, what would the time commitment and session schedule actually look like for me, and is that realistic given my current recovery stage and any caregiving or travel limitations I have?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.